60 Degrees Pharmaceuticals, Inc. Common Stock

SXTPNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
1.42 USD
↘ 0.11 (7.19%)AT CLOSE (11:59 AM EDT)
1.44
↗ 0.02 (1.41%)
POST MARKET (AS OF 06:49 PM EDT)
Post Market
AS OF 06:49 PM EDT
1.44
↗ 0.02 (1.41%)
🔴Market: CLOSED
Open?$1.54
High?$1.54
Low?$1.42
Prev. Close?$1.53
Volume?38.7K
Avg. Volume?55.5K
VWAP?$1.45
Rel. Volume?0.70x
Bid / Ask
Bid?$1.39 × 200
Ask?$1.55 × 100
Spread?$0.16
Midpoint?$1.47
Valuation & Ratios
Market Cap?3.8M
Shares Out?2.7M
Float?2.6M
Float %?98.3%
P/E Ratio?N/A
P/B Ratio?0.78
EPS?-$3.03
Dividend?0.00%
Ex-Dividend?N/A

Shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) are trading at $1.42. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Themes
Biotech - Drug Development›Infectious Disease & Vaccines
Employees
3
Market Cap
3.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.60degreespharma.com
Listed
2023-07-12
Address
1025 CONNECTICUT AVENUE NW
WASHINGTON, DC 20036
Phone: 202-327-5422
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
77
Short Sent.?
75
Piotroski F-Score?2/9Weak
Altman Z-Score?-12.13Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.46%Elevated
Short Interest?141.5K
Days to Cover?2.5
Free Float2.6M
Avg Daily Volume57.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.34Strong
Quick Ratio?2.85Strong
Cash Ratio?1.78Strong
Debt/Equity?0.03Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.78CHEAP▾
P/S?
Peers
100
S&P
52
2.87CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.44CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-167.0%WEAK▾
ROA?
S&P
3
-119.2%WEAK▾
Cash Flow & Enterprise
FCF?$-8160418
Enterprise Value?$581.6K
Fundamentals ratios updated end of day
MarketsMoversWatchlist